Oberweis Asset Management Inc Krystal Biotech, Inc. Transaction History
Oberweis Asset Management Inc
- $1.57 Billion
- Q2 2024
A detailed history of Oberweis Asset Management Inc transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Oberweis Asset Management Inc holds 42,600 shares of KRYS stock, worth $7.75 Million. This represents 0.5% of its overall portfolio holdings.
Number of Shares
42,600
Previous 35,700
19.33%
Holding current value
$7.75 Million
Previous $6.35 Million
23.16%
% of portfolio
0.5%
Previous 0.47%
Shares
2 transactions
Others Institutions Holding KRYS
# of Institutions
266Shares Held
25MCall Options Held
270KPut Options Held
172K-
Black Rock Inc. New York, NY3.95MShares$718 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.87MShares$522 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.43MShares$442 Million6.1% of portfolio
-
State Street Corp Boston, MA1.33MShares$242 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA1.02MShares$186 Million12.22% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.67B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...